German lung cancer incidence rises in women:
This article was originally published in Clinica
Executive Summary
The incidence of lung cancer in German women has risen dramatically in the last two decades, and while prevention following cutting out or down on tobacco has been successful in men, in women the same cannot be claimed. So says Christa Stegmaier, the head of the epidemiological cancer registry of the state of Saarland. Citing figures that are claimed to be representative for the whole of Germany, she said that lung cancer in Saarland women has risen by 173% in the last 20 years. A quarter of female lung cancer deaths were in the under-60 age bracket. Breast cancer is the leading female cancer in the state. In males, increased screening has seen prostate cancer overtake lung cancer as the leading form of the disease. Several thousand men had opted to take PSA tests under a programme organised by the Homburg Uniclinic, she said.
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.